BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 19, 2008
View Archived Issues
Responses seen with PF-00299804 in patients with advanced non-small cell lung cancer
Read More
Ardea Biosciences reports on gout and arthritis programs at EULAR
Read More
Data on GSK-1363089 in papillary renal carcinoma, gastric cancer presented
Read More
New agents for treating neurological disorders disclosed in recent NeuroSearch and reMYND patents
Read More
SkyePharma reports results from phase III efficacy study of Flutiform
Read More
US WorldMeds reports initial results from phase III clinical trial of lofexidine
Read More
PLx Pharma demonstrates bioequivalence with aspirin and PL-2100
Read More
Neurocrine completes six-month treatment phase in phase IIb trial of elagolix
Read More
GLP-1 Technosphere formulation enhances insulin release and lowers blood glucose in healthy subjects
Read More
Ghrelin agonist TZP-101 improves symptoms of gastroparesis in diabetic patients
Read More
Moderate improvement in rheumatoid arthritis symptoms with MAPK inhibitor VX-702
Read More
Phase I results reported for oncolytic compounds from Bristol-Myers Squibb
Read More
Protox granted orphan drug status in Europe for PRX-321 in brain cancer
Read More
Cipher's revised CIP-Tramadol ER NDA accepted for review by the FDA
Read More
Akesis announces positive results from phase IIa trial of AKP-020 in type 2 diabetes
Read More
Pivotal phase III Acurox trial meets primary endpoint
Read More
Recent Bristol-Myers Squibb patents report novel therapeutic agents for HCV infection
Read More
Novel antiinflammatory agents disclosed in joint AstraZeneca and Bayer Schering Pharma patent
Read More
ThromboGenics and BioInvent sign license agreement with Roche for anticancer drug TB-403
Read More
EMEA recommends that product information for Pfizer's Exubera include data on lung cancer
Read More
Hisamitsu and Kyowa enter joint sales agreement in Japan for HFT-290 for cancer pain
Read More
Aastrom to initiate phase II clinical trial of cardiac repair cells in DCM
Read More
Boehringer Ingelheim to acquire Actimis Pharmaceuticals
Read More
Huya completes pre-IND consultation meeting with the FDA for sulcardine sulfate
Read More
Nventa develops proprietary vaccine adjuvant, Poly-ICR
Read More
